Emigh James F

Avg. Two Year Performance

(48%) Avg. Purchase Return
(22%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(5%)5%(20%)(38%)(48%)
Purchase Success Rate1 of 21 of 21 of 20 of 20 of 2
Average Sale Return----------
Sale Success Rate----------

Acura Pharmaceuticals Inc.

Drugs » Drug Delivery

VP, Corporate Development:

Holdings: 474.04K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--